Correlation Between Beta Drugs and Titan Company

Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Titan Company at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Titan Company into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Beta Drugs and Titan Company Limited, you can compare the effects of market volatilities on Beta Drugs and Titan Company and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Titan Company. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Titan Company.

Diversification Opportunities for Beta Drugs and Titan Company

0.67

Correlation Coefficient

Beta Drugs  Titan Company

Poor diversification

The 3 months correlation between Beta and Titan is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Titan Company Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Titan Limited and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Titan Company. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Titan Limited has no effect on the direction of Beta Drugs i.e., Beta Drugs and Titan Company go up and down completely randomly.

Pair Corralation between Beta Drugs and Titan Company

Assuming the 90 days trading horizon Beta Drugs is expected to generate 2.58 times more return on investment than Titan Company. However, Beta Drugs is 2.58 times more volatile than Titan Company Limited. It trades about 0.0 of its potential returns per unit of risk. Titan Company Limited is currently generating about -0.05 per unit of risk. If you would invest  198,980  in Beta Drugs on December 30, 2024 and sell it today you would lose (8,430) from holding Beta Drugs or give up 4.24% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Beta Drugs  vs.  Titan Company Limited

Beta Drugs

Risk-Adjusted Performance

Very Weak

Over the last 90 days Beta Drugs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Beta Drugs is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Titan Limited

Risk-Adjusted Performance

Very Weak

Over the last 90 days Titan Company Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Titan Company is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Beta Drugs and Titan Company

The main advantage of trading using opposite Beta Drugs and Titan Company positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Titan Company can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Titan Company will offset losses from the drop in Titan Company's long position.

The idea behind Beta Drugs and Titan Company Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.